☆ 4.7 Review

Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes-A Systematic Review

JOURNAL OF CLINICAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Oral and intravenous iron treatment alter the gut microbiome differentially in dialysis patients

Huan Liu et al.

Summary: This study found that oral and intravenous iron therapy had different effects on the composition and diversity of gut microbiota. Oral iron reduced alpha-diversity, decreased the abundance of Firmicutes and Blautia, increased the abundance of Bacteroides and Lactobacillus, and increased the metabolic processes of phenylalanine, valine, leucine, and isoleucine. These findings suggest that intravenous iron may be more appropriate for maintenance hemodialysis patients.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2023)

Add to Collection
Article Nutrition & Dietetics

The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease

Xuechun Lin et al.

Summary: The present study revealed that patients with end-stage renal disease (ESRD) exhibit serious accumulation of indoxyl sulfate (IS) and p-cresyl sulfate (pCS), along with significant expansion of indole-producing bacteria and p-cresol-producing bacteria, upregulation of the bacterial tryptophan metabolism pathway, and greatly increased serum IS and pCS concentrations, whereas significant decline in daily IS and pCS removal.

JOURNAL OF RENAL NUTRITION (2022)

Add to Collection
Article Nutrition & Dietetics

Curcumin Supplementation (Meriva(R)) Modulates Inflammation, Lipid Peroxidation and Gut Microbiota Composition in Chronic Kidney Disease

Francesca Pivari et al.

Summary: Curcumin has the potential to be used as an adjunct therapy for treating chronic kidney disease by reducing inflammation and oxidative stress, and improving the quality of life for patients. Additionally, curcumin can modulate the gut microbiota, which may have inhibitory effects on CKD progression.

NUTRIENTS (2022)

Add to Collection
Article Nutrition & Dietetics

The Effect of ss-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial

Zarina Ebrahim et al.

Summary: There is growing evidence that gut dysbiosis contributes to the progression of chronic kidney disease. This study found that ss-glucan prebiotic has a positive effect on kidney function, uremic toxins, and the gut microbiome in CKD participants.

NUTRIENTS (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Preventing Bacterial Translocation in Patients with Leaky Gut Syndrome: Nutrition and Pharmacological Treatment Options

Agata Twardowska et al.

Summary: Leaky gut syndrome is a medical condition characterized by intestinal hyperpermeability. Changes in bacterial composition, decreased expression levels of tight junction proteins, and increased concentration of pro-inflammatory cytokines can lead to intestinal hyperpermeability and the development of various diseases. Translocation of microorganisms and their toxic metabolites beyond the gastrointestinal tract can cause chronic inflammation and progression of disorders. Dietary intervention has shown potential in improving barrier function and restricting bacterial invasion, but there are no medical guidelines for the treatment or prevention of bacterial translocation in patients with leaky gut syndrome.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection
Review Peripheral Vascular Disease

Recent advances in modulation of cardiovascular diseases by the gut microbiota

Sepiso K. Masenga et al.

Summary: This article explores the relationship between gut microbiota composition and cardiovascular diseases, as well as their association with CVD risk factors. It also mentions potential therapies for improving gut microbiota composition that may have positive effects on cardiovascular health.

JOURNAL OF HUMAN HYPERTENSION (2022)

Add to Collection
Article Urology & Nephrology

Exploration of the correlation between intestinal flora and Escherichia coli peritoneal dialysis-related peritonitis

Jun Zhou et al.

Summary: This study investigated the composition of gut microbiota in EP patients and found that the altered gut microbiota might be related to the pathogenesis of EP. Specifically, Bacteroidetes and Synergistetes were upregulated, while Bacilli and Lactobacillus were downregulated in EP patients. Moreover, decreased gene function associated with metabolic pathways was observed in EP patients.

BMC NEPHROLOGY (2022)

Add to Collection
Article Urology & Nephrology

Correlation between intestinal flora disruption and protein-energy wasting in patients with end-stage renal disease

Jianguang Hu et al.

Summary: This study examined the effects of different dialysis treatments on the composition and structure of the intestinal flora in chronic kidney disease (CKD) patients. The results showed that butyric acid-producing bacteria were positively correlated with protein-energy wasting (PEW) and negatively correlated with Escherichia. Improving intestinal diversity and increasing the amount of butyric acid-producing bacteria are potential therapeutic approaches to enhance protein-energy consumption in CKD patients with end-stage renal disease (ESRD).

BMC NEPHROLOGY (2022)

Add to Collection
Article Immunology

Clostridium species diversity in gut microbiota of patients with renal failure

Siamak Amini Khiabani et al.

Summary: The abundance of Clostridium species in the gut microbiota of patients with kidney failure is similar to that of healthy individuals, indicating that some pathogens and their metabolites may not play a role in the pathogenesis of kidney disorders.

MICROBIAL PATHOGENESIS (2022)

Add to Collection
Article Multidisciplinary Sciences

Impact of sucroferric oxyhydroxide on the oral and intestinal microbiome in hemodialysis patients

Mohamed M. H. Abdelbary et al.

Summary: This study investigated the effects of a Fe(3+)-based phosphate binder on the oral and gastrointestinal microbiome of hemodialysis patients. Overall, the microbiome did not change significantly, but there were individual differences. Bacterial taxa that benefited from iron abundance lacked iron-binding siderophores or alternatives, while those that declined under iron abundance possessed these alternatives. Patients with microbiome shift were younger and had higher serum phosphate concentrations.

SCIENTIFIC REPORTS (2022)

Add to Collection
Article Immunology

Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia

Yifan Zhu et al.

Summary: This study explores the changes in gut microbiota between ESRD patients with different responsiveness to EPO treatment and finds significant differences in gut microbiota composition between poor-response and good-response patients. By analyzing specific genera of gut microbiota, the occurrence of EPO hyporesponsiveness (EH) can be predicted accurately. Furthermore, certain genera of gut microbiota have a protective effect against EH. These findings provide new insights into the pathogenesis of renal anemia and suggest the potential role of gut microbiota in EPO treatment.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Add to Collection
Review Endocrinology & Metabolism

A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals

Shisheng Han et al.

Summary: This study reviewed the differences in gut microbiota associated with diabetic kidney disease (DKD). The results showed that there were lower levels of microbial richness in DKD compared to healthy controls and different bacterial compositions between DKD and non-DKD subjects. The enrichment of genera Hungatella and Escherichia, as well as the depletion of butyrate-producing bacteria, were observed in DKD. These alterations in gut microbiota might be associated with the occurrence and development of DKD.

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection
Review Food Science & Technology

Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials

Hui Juan Zheng et al.

Summary: This study systematically evaluated the effects of probiotic, prebiotic, and synbiotic supplements on biomarkers of inflammation, oxidative stress, and lipid profiles in patients with chronic kidney disease. The results showed that microbial therapies significantly lowered levels of inflammatory and oxidative stress biomarkers, as well as improved lipid profiles, highlighting the potential of these supplements in improving cardiovascular risk factors in CKD patients.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2021)

Add to Collection
Article Transplantation

Association of subjective global assessment of nutritional status with gut microbiota in hemodialysis patients: a case-control study

Ting-Yun Lin et al.

Summary: In hemodialysis patients, protein-energy wasting (PEW) assessed with the subjective global assessment (SGA) score is associated with gut dysbiosis. Patients with PEW have lower gut microbial diversity, while those with normal nutritional status have higher body mass index, physical activity, and serum albumin levels.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Add to Collection
Article Transplantation

Metagenomic profiling of gut microbiome in early chronic kidney disease

Noriaki Sato et al.

Summary: By analyzing the differences in gut microbiome between diabetic and non-diabetic participants, the study found subtle changes in the gut microbiome of individuals with early CKD, with alterations related to short-chain fatty acid production already observable in early stages of CKD.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Add to Collection
Review Urology & Nephrology

Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review

Jin Zhao et al.

Summary: The dysbiosis of gut microbiota has been found to be associated with chronic kidney disease (CKD), with specific alterations in microbial parameters identified in patients. However, differences in methodology and reporting among studies have prevented a complete understanding of the gut microbiota in CKD patients.

RENAL FAILURE (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Gut Microbiome Composition Remains Stable in Individuals with Diabetes-Related Early to Late Stage Chronic Kidney Disease

Ashani Lecamwasam et al.

Summary: Individuals with diabetes and chronic kidney disease show gut dysbiosis, with Firmicutes and Bacteroidetes as predominant phyla. The relative abundance of these gut microbes does not change across the early and late stages of diabetic chronic kidney disease, suggesting it is an early event in disease development.

BIOMEDICINES (2021)

Add to Collection
Review Biochemistry & Molecular Biology

The Link Between Bacterial Inflammagens, Leaky Gut Syndrome and Colorectal Cancer

Greta M. de Waal et al.

Summary: Colorectal cancer, chronic systemic inflammation, and persistent infections are causally related with dysregulated circulating inflammatory markers. Gut dysbiosis and inflammatory profile are closely linked in colorectal cancer. Bacterial influx in the internal environment and release of potent inflammagenic molecules play a significant role in inflammation and potentially cancer development, particularly in colorectal cancer.

CURRENT MEDICINAL CHEMISTRY (2021)

Add to Collection
Article Medicine, General & Internal

Ketoanalogs' Effects on Intestinal Microbiota Modulation and Uremic Toxins Serum Levels in Chronic Kidney Disease (Medika2 Study)

Maria Teresa Rocchetti et al.

Summary: This study aimed to evaluate the specific effect of ketoanalogs (KA)-supplemented diets for gut microbiota modulation in CKD patients. The results showed that KA-supplemented MD reduced certain microbial families and decreased levels of harmful substances, but was not as effective as the VLPD.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection
Article Biotechnology & Applied Microbiology

Gut dysbiosis and mortality in hemodialysis patients

Ting-Yun Lin et al.

Summary: The relationship between gut dysbiosis, inflammation, and adverse outcomes in chronic kidney disease patients is still unclear. Higher microbial diversity in hemodialysis patients is associated with a 74% lower risk of death. Nonsurvivors have lower microbial diversity and higher proinflammatory cytokine levels, with reduced abundance of certain beneficial bacteria like Succinivibrio and Anaerostipes.

NPJ BIOFILMS AND MICROBIOMES (2021)

Add to Collection
Article Nutrition & Dietetics

Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): A Feasibility Randomized Controlled Trial

Catherine McFarlane et al.

Summary: The study evaluated the feasibility and effects of synbiotic supplementation in CKD patients, finding that synbiotics altered the gut microbiome and led to a decrease in kidney function.

NUTRIENTS (2021)

Add to Collection
Article Multidisciplinary Sciences

Butyrate producing microbiota are reduced in chronic kidney diseases

Bei Gao et al.

Summary: This study identified taxonomic and functional signatures associated with disease severity in patients with chronic kidney disease through shot-gun metagenomics sequencing, providing valuable information for the development of microbiota-oriented therapeutic strategies for chronic kidney disease.

SCIENTIFIC REPORTS (2021)

Add to Collection
Review Immunology

Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species

Kai Nie et al.

Summary: Roseburia intestinalis, a bacterium that produces butyrate in the colon, has been shown to play a crucial role in preventing intestinal inflammation and maintaining energy homeostasis. Patients with inflammatory bowel disease may benefit from modulating the abundance of R. intestinalis. Recent advancements in research technologies have revealed the therapeutic potential of this bacterium in human health and disease treatment.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Add to Collection
Article Microbiology

Sex Differences in Fecal Microbiota Correlation With Physiological and Biochemical Indices Associated With End-Stage Renal Disease Caused by Immunoglobulin a Nephropathy or Diabetes

Peng Zhang et al.

Summary: This study revealed sex-specific differences in the correlation between intestinal microbiota and end-stage renal disease, highlighting potential variations in the effectiveness of ESRD prevention and treatments through regulation of intestinal microbiota.

FRONTIERS IN MICROBIOLOGY (2021)

Add to Collection
Article Health Care Sciences & Services

Gut Microbiome Profiling Uncovers a Lower Abundance of Butyricicoccus in Advanced Stages of Chronic Kidney Disease

Tessa Gryp et al.

Summary: This study did not observe gradual differences in the gut microbial profile among patients in different stages of chronic kidney disease. However, a decrease in the abundance of Butyricicoccus genus with loss of kidney function was identified, underscoring the need for further in-depth exploration of the gut microbiome in CKD patients not on dialysis.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection
Article Urology & Nephrology

Gut microbiota in Immunoglobulin A Nephropathy: a Malaysian Perspective

Agni Nhirmal Kumar Sugurmar et al.

Summary: While no significant differences were found in OTU and alpha diversity between IgAN patients in remission and healthy controls, there were differences at the phylum level between the two groups. Additionally, alpha diversity increased with increasing CKD stage.

BMC NEPHROLOGY (2021)

Add to Collection
Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection
Article Immunology

The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses

Dan Luo et al.

Summary: Alterations in gut microbiota were observed in end-stage renal disease (ESRD) patients with or without dialysis. Dialysis reversed abnormal changes in certain bacterial genera in pre-dialysis patients. Functional predictions of microbial communities showed that peritoneal dialysis (PD) and hemodialysis (HD) altered signal transduction and metabolic pathways in ESRD patients. Certain gut bacteria were associated with cardiovascular mortality and peritonitis in ESRD patients. This study suggested a potential impact of gut bacteria on patient prognosis.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Add to Collection
Article Immunology

Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains

Fengping Liu et al.

Summary: This study confirmed gut dysbiosis in patients with chronic kidney disease (CKD) while investigating the impact of the microbiome on CKD and its association with serum free immunoglobulin light chain (FLC) levels. The results showed a significant difference in bacterial community between CKD patients and healthy controls, with specific bacterial enrichments and metabolic pathways predicting CKD prevalence and FLC levels. The findings indicate a crosstalk between the microbiome and immune response in CKD, highlighting the importance of gut dysbiosis in the pathogenesis of the disease.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Article Food Science & Technology

The Impact of Enriched Resistant Starch Type-2 Cookies on the Gut Microbiome in Hemodialysis Patients: A Randomized Controlled Trial

Julie Ann Kemp et al.

Summary: Enriched RS2 cookies significantly alter the gut microbiota composition in hemodialysis patients, leading to changes in the levels of SCFA producers and potentially serving as a beneficial nutritional strategy for patients with chronic kidney disease on hemodialysis.

MOLECULAR NUTRITION & FOOD RESEARCH (2021)

Add to Collection
Article Medicine, General & Internal

Gut Microbiota Composition and Its Metabolites in Different Stages of Chronic Kidney Disease

Tso-Hsiao Chen et al.

Summary: This study identified gut microbiota and metabolites correlated with CKD severity and may have important implications for the deterioration of CKD patients. These microbiota or metabolite changes could potentially serve as candidates for evaluating the progression of CKD.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection
Article Endocrinology & Metabolism

Alteration of gut microbial profile in patients with diabetic nephropathy

Xi Du et al.

Summary: Investigations have shown that 30-40% of patients with diabetes develop diabetic nephropathy (DN). The gut microbiome has become a lively field of research in diabetes mellitus and chronic kidney disease. This study analyzed the gut microbial profiles in DN patients and healthy controls, revealing differences in microbial profiles based on disease stages, gender, and BMI. The results demonstrated dysbiosis and a decrease in gut bacterial richness and diversity in DN patients compared to healthy controls. Additionally, certain genera identified in the study may serve as potential microbial biomarkers for DN.

ENDOCRINE (2021)

Add to Collection
Review Medicine, Research & Experimental

Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation

Zaker I. Schwabkey et al.

ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)

Add to Collection
Article Nutrition & Dietetics

Effect of probiotics on the intestinal microbiota of hemodialysis patients: a randomized trial

Sixiu Liu et al.

EUROPEAN JOURNAL OF NUTRITION (2020)

Add to Collection
Article Urology & Nephrology

High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients

Jianguang Hu et al.

BMC NEPHROLOGY (2020)

Add to Collection
Article Neuroimaging

Gut dysbiosis-influence on amygdala-based functional activity in patients with end stage renal disease: a preliminary study

Li Juan Zheng et al.

BRAIN IMAGING AND BEHAVIOR (2020)

Add to Collection
Article Urology & Nephrology

Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis

Akira Iguchi et al.

CLINICAL AND EXPERIMENTAL NEPHROLOGY (2020)

Add to Collection
Article Gastroenterology & Hepatology

Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents

Xifan Wang et al.

GUT (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients

Tessa Gryp et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection
Article Endocrinology & Metabolism

Characterization of Gut Microbiota Composition in Hemodialysis Patients With Normal Weight Obesity

Ting-Yun Lin et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Add to Collection
Article Multidisciplinary Sciences

Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease

Elisabetta Margiotta et al.

PLOS ONE (2020)

Add to Collection
Article Medicine, General & Internal

Characterizing the gut microbiota in patients with chronic kidney disease

Xiaofang Hu et al.

POSTGRADUATE MEDICINE (2020)

Add to Collection
Review Cardiac & Cardiovascular Systems

Gut Microbiota and Cardiovascular Disease

Marco Witkowski et al.

CIRCULATION RESEARCH (2020)

Add to Collection
Article Biotechnology & Applied Microbiology

Effect of Different Hemodialysis Methods on Microbiota in Uremic Patients

Haidong He et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Add to Collection
Article Microbiology

The Association between Gut Microbiota and Uremia of Chronic Kidney Disease

Ji Eun Kim et al.

MICROORGANISMS (2020)

Add to Collection
Article Medicine, Research & Experimental

Intestinal flora alterations in patients with early chronic kidney disease: a case-control study among the Han population in southwestern China

Qiongdan Hu et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)

Add to Collection
Article Immunology

Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome

Jun Zhang et al.

MICROBIAL PATHOGENESIS (2020)

Add to Collection
Article Gastroenterology & Hepatology

The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics

Kelly S. Swanson et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection
Article Nutrition & Dietetics

Compositional and Functional Adaptations of Intestinal Microbiota and Related Metabolites in CKD Patients Receiving Dietary Protein Restriction

I-Wen Wu et al.

NUTRIENTS (2020)

Add to Collection
Article Chemistry, Multidisciplinary

Alterations of the Human Gut Microbiome in Chronic Kidney Disease

Zhigang Ren et al.

ADVANCED SCIENCE (2020)

Add to Collection
Article Microbiology

Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease

Ping-Hsun Wu et al.

MICROORGANISMS (2020)

Add to Collection
Article Medicine, Research & Experimental

Colon Microbiocenosis and Its Correction in Patients Receiving Programmed Hemodialysis

I. Belova et al.

SOVREMENNYE TEHNOLOGII V MEDICINE (2020)

Add to Collection
Article Medicine, Research & Experimental

Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease

I-Wen Wu et al.

THERANOSTICS (2020)

Add to Collection
Article Medicine, Research & Experimental

Changes in the Intestinal Microbiota in Patients with Stage 5 Chronic Kidney Disease on a Low-Protein Diet and the Effects of Human to Rat Fecal Microbiota Transplantation

Shuning Jiang et al.

MEDICAL SCIENCE MONITOR (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Gut Microbiota as Diagnostic Tools for Mirroring Disease Progression and Circulating Nephrotoxin Levels in Chronic Kidney Disease: Discovery and Validation Study

I-Wen Wu et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Add to Collection
Article Nutrition & Dietetics

An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD)

Mariadelina Simeoni et al.

EUROPEAN JOURNAL OF NUTRITION (2019)

Add to Collection
Article Immunology

Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease

FengXia Li et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Add to Collection
Article Medicine, Research & Experimental

Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease

Siqi Wang et al.

CLINICAL SCIENCE (2019)

Add to Collection
Article Medicine, General & Internal

RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Add to Collection
Review Immunology

Bifidobacterial Dialogue With Its Human Host and Consequent Modulation of the Immune System

Giulia Alessandri et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection
Article Microbiology

Altered gut microbiota and microbial biomarkers associated with chronic kidney disease

Hengzhong Lun et al.

MICROBIOLOGYOPEN (2019)

Add to Collection
Article Nutrition & Dietetics

Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease

Silvia Lai et al.

NUTRIENTS (2019)

Add to Collection
Article Medicine, Research & Experimental

The gut microbiota-inflammation-brain axis in end-stage renal disease: perspectives from default mode network

Yun Fei Wang et al.

THERANOSTICS (2019)

Add to Collection
Review Food Science & Technology

Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications

Dorna Davani-Davari et al.

FOODS (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy

Esther Forkosh et al.

OPEN HEART (2019)

Add to Collection
Review Microbiology

What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases

Emanuele Rinninella et al.

MICROORGANISMS (2019)

Add to Collection
Article Gastroenterology & Hepatology

Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice

Arno Hanninen et al.

GUT (2018)

Add to Collection
Article Nutrition & Dietetics

Probiotic Supplementation in Chronic Kidney Disease: A Double-blind, Randomized, Placebo-controlled Trial

Natalia A. Borges et al.

JOURNAL OF RENAL NUTRITION (2018)

Add to Collection
Article Microbiology

Circadian Disruption Changes Gut Microbiome Taxa and Functional Gene Composition

Jessica A. Deaver et al.

FRONTIERS IN MICROBIOLOGY (2018)

Add to Collection
Review Pediatrics

Gut microbiome and kidney disease: a bidirectional relationship

Souhaila Al Khodor et al.

PEDIATRIC NEPHROLOGY (2017)

Add to Collection
Article Gastroenterology & Hepatology

Circulating and Tissue-Resident CD4+ T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation

Ahmed N. Hegazy et al.

GASTROENTEROLOGY (2017)

Add to Collection
Article Transplantation

Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease

Lama Nazzal et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)

Add to Collection
Article Multidisciplinary Sciences

Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis

Vanessa Stadlbauer et al.

SCIENTIFIC REPORTS (2017)

Add to Collection
Article Medicine, General & Internal

Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD

Mohammed A. I. Al-Obaide et al.

JOURNAL OF CLINICAL MEDICINE (2017)

Add to Collection
Article Multidisciplinary Sciences

Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial

Rabi Yacoub et al.

PLOS ONE (2017)

Add to Collection
Article Multidisciplinary Sciences

Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients

Kai-Yu Xu et al.

SCIENTIFIC REPORTS (2017)

Add to Collection
Article Multidisciplinary Sciences

Alteration of the gut microbiota in Chinese population with chronic kidney disease

Shuanghong Jiang et al.

SCIENTIFIC REPORTS (2017)

Add to Collection
Article Urology & Nephrology

Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target

Ali Ramezani et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2016)

Add to Collection
Article Microbiology

A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression

Shuanghong Jiang et al.

ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2016)

Add to Collection
Article Urology & Nephrology

Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial

Megan Rossi et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Add to Collection
Article Microbiology

Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem?

Alexis Mosca et al.

FRONTIERS IN MICROBIOLOGY (2016)

Add to Collection
Article Microbiology

Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?

Amanda F. Barros et al.

FUTURE MICROBIOLOGY (2015)

Add to Collection
Article Urology & Nephrology

Cause-Specific Deaths in Non-Dialysis-Dependent CKD

Sankar D. Navaneethan et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Add to Collection
Review Gastroenterology & Hepatology

Role of the normal gut microbiota

Sai Manasa Jandhyala et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Add to Collection
Article Nutrition & Dietetics

Effects of a Symbiotic on Gut Microbiota in Mexican Patients With End-Stage Renal Disease

Jose Cruz-Mora et al.

JOURNAL OF RENAL NUTRITION (2014)

Add to Collection
Review Endocrinology & Metabolism

Minireview: Gut Microbiota: The Neglected Endocrine Organ

Gerard Clarke et al.

MOLECULAR ENDOCRINOLOGY (2014)

Add to Collection
Article Gastroenterology & Hepatology

The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

Colin Hill et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)

Add to Collection
Article Infectious Diseases

The microbiome as a human organ

F. Baquero et al.

CLINICAL MICROBIOLOGY AND INFECTION (2012)

Add to Collection
Editorial Material Public, Environmental & Occupational Health

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Andreas Stang

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)

Add to Collection
Review Biochemistry & Molecular Biology

The gut flora as a forgotten organ

Ann M. O'Hara et al.

EMBO REPORTS (2006)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.